Phase II 5-Azacytidine Plus VPA Plus ATRA
|2||Active, not recruiting||
Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
|3||Active, not recruiting||
Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid
† Study has passed its completion date and status has not been verified in more than two years.